Kristin Torres Mowat joins Health Velocity Capital as Partner

Health Velocity Capital
4 min readJul 13, 2021

San Francisco, CA., July 13, 2021. Health Velocity Capital, a growth-stage investment firm focused exclusively on financing and helping to build innovative healthcare software and services businesses, is pleased to announce the addition of Kristin Torres Mowat. Ms. Torres Mowat is joining the firm in the role of Partner + Strategic Networks.

Health Velocity Capital has a unique limited partner base that consists of traditional institutional investors (including leading, global endowments, foundations, pension plans, and fund of funds); some of the largest and most influential health plans, health systems, and health technology companies in the nation; and more than 100 senior healthcare executives who have invested personally in Health Velocity Capital’s funds. Collectively, these limited partners represent organizations that insure more than 150 million Americans, operate more than 600 hospitals, provide pharmacy and PBM services to everyone in the nation, provide software to every major health system in the nation, employ more than 3.5 million Americans, and generate almost $2 trillion in annual revenue. In her role, Ms. Torres Mowat will focus on continuing to optimize the firm’s best-in-class processes to create symbiotic value-add within this unique limited partner base and will also contribute to all aspects of the firm’s investing efforts.

“We are thrilled to welcome Kristin to our team”, noted Marty Felsenthal, Partner at Health Velocity Capital. “Our mission at Health Velocity Capital is to generate outstanding financial returns while being the preferred partner of entrepreneurs and investors working toward a more affordable, sustainable, consumer friendly healthcare system. We do this by fostering a highly symbiotic environment between our strategic investors and senior healthcare executive investors on the one hand and innovators from within and outside of our portfolio on the other. We believe Kristin brings outstanding and extremely relevant experience to this role given her successful track record across both the provider, employer, and payer market segments as well as across legacy healthcare leaders and innovators.”

Bruce Crosby, also a Partner at Health Velocity Capital added, “Healthcare represents the largest sector of the U.S. economy with per capita costs continually outpacing those of other industrialized nations and clinical outcomes that do not reflect this incremental spending. We are committed to helping our strategic limited partners identify the right innovative themes and companies at the right time as they address a national imperative and further believe Kristin brings an extraordinary background and set of experiences to help us in this pursuit.”

“I am honored to join this special team,” Ms. Torres Mowat added. “I look forward to serving our investors and entrepreneurs and adding to the deep investment experience, domain expertise, and expansive networks for which Health Velocity Capital truly stands out. I believe there has never been a better time to build more successful healthcare innovators and to build them bigger and faster; this is of critical importance to our country as we push toward a high quality, lower cost, and consumer-friendly healthcare system. I am excited to continue to support entrepreneurs in their efforts to scale impactful innovation as quickly as possible.”

Ms. Torres Mowat most recently served as SVP Corporate Development for Castlight Health, a publicly traded healthcare technology company where she built and managed the portfolio of medical, pharmacy, dental, and behavioral health plan relationships, built and managed the company’s data operations capabilities, and also led Castlight’s strategic growth efforts and partnerships. During this time the company grew to more than 20 million members. Previously, Ms. Torres Mowat was Vice President at DaVita Inc., a Fortune 200 company and one of the largest global healthcare services providers. At DaVita, she was responsible for Corporate Strategy, founded and ran the company’s specialty EHR business, and led recruiting for the Leadership Development Program. She began her career at Bain & Co.

Ms. Torres Mowat earned her BA, JD, and MBA from Stanford University and has also been an individual investor in, and advisor to numerous healthcare software and services companies. She currently serves as a Director of Women’s Health USA and In Vitro Sciences.

About Health Velocity Capital

Health Velocity Capital invests exclusively in innovative healthcare software and services companies. The firm’s partners have more than 60 collective years as investors, entrepreneurs, and executives helping to finance and build innovative companies that created important new healthcare markets and that became market leaders, including successful companies such as Teladoc, Livongo Health, Change Healthcare, MDLive, Aspire Health, Ginger, Zipari, Compassus, Aperio, The Advisory Board Company, Healthways (Tivity Health), US Renal Care, IVX Health, Spero Health, OnShift, Vantage Oncology, D2Hawkeye, Contessa Health, Circulation Health, Payerpath, and many others. In addition to investing on behalf of institutional investors, Health Velocity Capital invests on behalf of a number of the nation’s largest and most influential healthcare organizations and many of their top executives who collectively represent organizations that provide health insurance to more than 150 million Americans, operate more than 600 hospitals, provide pharmacy and PBM services to all Americans, and provide software and services to every major hospital in the United States. For more information, please visit www.healthvelocitycapital.com.

--

--

Health Velocity Capital

Health Velocity Capital invests in growth stage healthcare companies contributing to a more affordable, sustainable, and consumer-friendly healthcare system.